Saibeni S, Etchevers MJ, Tàssies D, Panés J, Reverter JC, Danese S, Piqué JM, Bruno S, Vecchi M, Gasbarrini A, Sans M
Int J Colorectal Dis. 2013 Sep;28(9):1281-6, PMID: 23588875
In inflammatory bowel diseases (IBD), risk of thrombosis and production of antibodies are increased. In autoimmune and inflammatory disorders, a role of anti-prothrombin (aPT) antibodies in developing thrombosis has been hypothesised. The aim of the study is to evaluate the prevalence of aPT antibodies in IBD patients, with and without thrombosis.
GASTROENTEROLOGY & HEPATOLOGY